A Review of Data on Optimal Sequencing and Combinations of Current Therapies in Renal Cell
March 4th 2011The past 2 to 3 decades saw a palpable therapeutic nihilism associated with the management of patients with advanced renal cell carcinoma (RCC), interrupted briefly by the initial excitement regarding high-dose interleukin-2.
Read More